Chronic histiocytic intervillositis: Outcome, associated diseases and treatment in a multicenter prospective study

Autoimmunity

Volumn 48, Issue 1, 2015, Pages 40-45

  Mekinian, Arsène ^a   Costedoat Chalumeau, Nathalie ^b   Masseau, Agathe ^c   Botta, Angela ^d   Chudzinski, Anastasia ^e   Theulin, Arnaud ^f   Emmanuelli, Virginie ^e   Hachulla, Eric ^e   De Carolis, Sara ^d   Revaux, Aurélie ^g   Nicaise, Pascale ^b   Cornelis, Françoise ^g   Subtil, Damien ^e   Montestruc, Francois ^h   Bucourt, Martine ^g   Chollet Martin, Sylvie ^b   Carbillon, Lionel ^g   Fain, Olivier ^a  

^a UNIVERSITÉ PARIS 13   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIV LILLE   (France)

^f UNIVERSITÉ DE STRASBOURG   (France)

^g HÔPITAL JEAN VERDIER   (France)

^h EXYSTAT SAS   (France)

Author keywords

Autoimmune disease; Chronic histiocytic intervillositis; Outcome; Treatment

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC HISTIOCYTIC INTERVILLOSITIS; CLINICAL ARTICLE; FEMALE; FETUS DEATH; HUMAN; LIVE BIRTH; MULTICENTER STUDY; PLACENTA DISORDER; PRENATAL GROWTH; RECURRENT DISEASE; RISK FACTOR; ABORTION, HABITUAL; AUTOIMMUNE DISEASES; BLOOD; CELL MOVEMENT; CHORIONIC VILLI; CLINICAL TRIAL; COMPLICATION; FETAL DEATH; HISTIOCYTES; HUMANS; IMMUNOLOGY; INFANT, NEWBORN; OBSTETRIC LABOR, PREMATURE; PATHOLOGY; PREGNANCY; PREVENTION AND CONTROL; PROSPECTIVE STUDIES; RECURRENCE;

ASPIRIN; AUTOANTIBODIES; HEPARIN, LOW-MOLECULAR-WEIGHT; HYDROXYCHLOROQUINE; PREDNISONE;

ABORTION, HABITUAL; ADULT; ASPIRIN; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CELL MOVEMENT; CHORIONIC VILLI; FEMALE; FETAL DEATH; HEPARIN, LOW-MOLECULAR-WEIGHT; HISTIOCYTES; HUMANS; HYDROXYCHLOROQUINE; INFANT, NEWBORN; LIVE BIRTH; OBSTETRIC LABOR, PREMATURE; PREDNISONE; PREGNANCY; PROSPECTIVE STUDIES; RECURRENCE;

EID: 84919799180     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2014.939267     Document Type: Article

References (19)

1. Labarrere, C., and E. Mullen. 1987. Fibrinoid and trophoblastic necrosis with massive chronic intervillositis: an extreme variant of villitis of unknown etiology. Am. J. Reprod. Immunol. Microbiol. 15:85-91.
2. Jacques, S. M., and F. Qureshi. 1993. Chronic intervillositis of the placenta. Arch. Pathol. Lab. Med. 117:1032-1035.
3. Doss, B. J., M. F. Greene, J. Hill, et al. 1995. Massive chronic intervillositis associated with recurrent abortions. Hum. Pathol. 26: 1245-1251.
4. Redline, R. W., M. Zaragoza, and T. Hassold. 1999. Prevalence of developmental and inflammatory lesions in nonmolar first-trimester spontaneous abortions. Hum. Pathol. 30:93-100.
5. Boyd, T. K., and R. W. Redline. 2000. Chronic histiocytic intervillositis: a placental lesion associated with recurrent reproductive loss. Hum. Pathol. 31:1389-1396.
6. Boog, G., C. Le Vaillant, F. Alnoukari, et al. 2006. Combining corticosteroid and aspirin for the prevention of recurrent villitis or intervillositis of unknown etiology. J. Gynecol. Obstet. Biol. Reprod. (Paris) 35:396-404.
7. Rota, C., D. Carles, V. Schaeffer, et al. 2006. Perinatal prognosis of pregnancies complicated by placental chronic intervillitis. J. Gynecol. Obstet. Biol. Reprod. (Paris) 35:711-719.
8. Parant, O., J. Capdet, S. Kessler, et al. 2009. Chronic intervillositis of unknown etiology (CIUE): relation between placental lesions and perinatal outcome. Eur. J. Obstet. Gynecol. Reprod. Biol. 143: 9-13.
9. Contro, E., R. deSouza, and A. Bhide. 2010. Chronic intervillositis of the placenta: a systematic review. Placenta. 31: 1106-1110.
10. Marchaudon, V., L. Devisme, S. Petit, et al. 2010. Chronic histiocytic intervillositis of unknown etiology: clinical features in a consecutive series of 69 cases. Placenta. 32: 140-145.
11. Traeder, J., D. Jonigk, H. Feist, et al. 2010. Pathological characteristics of a series of rare chronic histiocytic intervillositis of the placenta. Placenta. 31:1116-1119.
12. Wilson, W. A., A. E. Gharavi, T. Koike, et al. 1999. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 42:1309-1311.
13. Miyakis, S., M. D. Lockshin, T. Atsumi, et al. 2006. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4: 295-306.
14. Capuani, C., F. Meggetto, I. Duga, et al. 2012. Specific infiltration pattern of FOXP3+ regulatory T cells in chronic histiocytic intervillositis of unknown etiology. Placenta. 34:149-154.
15. Salafia, C., D. Maier, C. Vogel, et al. 1993. Placental and decidual histology in spontaneous abortion: detailed description and correlations with chromosome number. Obstet. Gynecol. 82:295-303.
16. Salafia, C. M., and F. S. Cowchock. 1997. Placental pathology and antiphospholipid antibodies: a descriptive study. Am. J. Perinatol. 14:435-441.
17. Freitag, L., C. von Kaisenberg, H. Kreipe, and K. Hussein. 2013. Expression analysis of leukocytes attracting cytokines in chronic histiocytic intervillositis of the placenta. Int. J. Clin. Exp. Pathol. 6: 1103-1111.
18. Reus, A. D., N. M. van Besouw, N. M. Molenaar, et al. 2013. An immunological basis for chronic histiocytic intervillositis in recurrent fetal loss. Am. J. Reprod. Immunol. 70:230-237.
19. Rovere-Querini, P., M. T. Castiglioni, M. G. Sabbadini, and A. A. Manfredi. 2007. Signals of cell death and tissue turnover during physiological pregnancy, pre-eclampsia, and autoimmunity. Autoimmunity. 40:290-294.